[1]阳荣,牟吉,周龙,等.Spinophilin的表达与垂体腺瘤侵袭性的关系[J].中国临床神经外科杂志,2022,27(05):373-375.[doi:10.13798/j.issn.1009-153X.2022.05.012]
　YANG Rong,MOU Ji,ZHOU Long,et al.Expression of Spinophilin in pituitary adenoma tissues and its relationship with tumor invasiveness[J].,2022,27(05):373-375.[doi:10.13798/j.issn.1009-153X.2022.05.012]
点击复制

Spinophilin的表达与垂体腺瘤侵袭性的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年05期
页码:
373-375
栏目:
论著
出版日期:
2022-05-31

文章信息/Info

Title:
Expression of Spinophilin in pituitary adenoma tissues and its relationship with tumor invasiveness
文章编号:
1009-153X(2022)05-0373-03
作者:
阳荣; 牟吉; 周龙; 田仁富
445500湖北，恩施土家族苗族自治州中心医院神经外科（阳荣、牟吉、周龙、田仁富）
Author(s):
YANG Rong;  MOU Ji;  ZHOU Long;  TIAN Ren-fu
Department of Neurosurgery, Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Enshi 445500, China
关键词:
垂体腺瘤; Spinophilin; 肿瘤侵袭性; 基因表达
Keywords:
Pituitary adenoma;  Spinophilin;  Tumor invasion;  Gene expression
分类号:
R739.41;Q786
DOI:
10.13798/j.issn.1009-153X.2022.05.012
文献标志码:
A
摘要:
目的 探讨垂体腺瘤（PA）组织Spinophilin（SPN）的表达及其与腺瘤侵袭性的关系。方法 选取2018年8月至2021年6月手术切除并经术后病理确诊的PA组织98例和瘤旁组织64例，用免疫组化染色检测SPN蛋白表达水平，应用PCR检查PA组织SPN mRNA表达水平。根据Knosp分类法评估肿瘤侵袭性。结果 98例中，侵袭性46例，非侵袭性52例。PA组织SPN阳性表达率（21.43%，21/98）明显低于瘤旁组织（71.87%，46/64；P<0.05）。侵袭性PA组织SPN阳性表达率（13.04%，6/46）明显低于非侵袭性PA组织（28.85%，15/52；P<0.05）。PA组织SPN mRNA相对表达量（1.21±0.37）明显低于瘤旁组织（2.89±0.75；P<0.05）。SPN阴性表达（OR=2.876；95%CI 1.003~5.121；P<0.001）是PA侵袭性的独立危险因素。ROC曲线分析显示，SPN mRNA预测PA侵袭性的AUC为0.830（95%CI 0.813~0.916；P<0.001），诊断临界值为0.84，灵敏度和特异度分别为95.23%和83.12%。结论 侵袭性PA组织SPN呈低表达，检测SPN表达水平对PA侵袭性有一定评估作用。
Abstract:
Objective To investigate the relationship of Spinophilin (SPN) expression in pituitary adenoma (PA) tissues and tumor invasiveness. Methods The SPN expression was detected in PA tissues obtained from 98 PA patients who underwent microsurgery from August 2018 to June 2021 and in 64 paratumor tissues. The expression level of SPN mRNA was detected by real-time fluorescent PCR in PA tissues. PA invasiveness was assessed by Knsop grdea. Results Of 98 PA patients, 46 patients were classified as invasive PA and 52 non-invasive. The positive rate of SPN expression in paratumor tissues (71.87%, 46/64) was significantly higher than that in PA tissues (21.43%, 21/98; P<0.05). The positive rate of SPN expression in invasive PA tissues (13.04%, 6/46) was signifcnatly lower than that (28.85%, 15/52) in non-invasive PA tissues (P<0.05). The relative expression of SPN mRNA in PA tissues (1.21±0.37) was significantly lower than that (2.89±0.75) in paratumor tissue (P<0.05). The relative expression of SPN mRNA in invasive PA tissues (0.73±0.16) was significantly lower than that (1.68±0.80) in non-invasive PA tissues (P<0.05). Multivariate logistic regression analysis showed that negative expression of SPN was an independent risk factor of PA invasion (OR=2.876; 95%CI 1.003~5.121; P<0.05). ROC curve analysis showed that the AUC of SPN mRNA≥0.84 for predicting PA invasion was 0.830, with a sensitivity and specificity of 95.23% and 83.12%, respectively. Conclusions The expression of SPN in invasive PA tissues is low, and the detection of SPN expression has a certain value in assessing the invasiveness of PA.

参考文献/References:

[1] 朱惠娟，王任直. 垂体腺瘤临床诊治进展[J]. 协和医学杂 志，2020，11（5）：533-536.
[2] Li J, Qian Y, Zhang C, et al. LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion [J]. Cell Death Dis, 2021, 12(6): 580.
[3] Zhou R, Wu Q, Wang M, et al. The protein phosphatase PPM1A dephosphorylates and activates YAP to govern mammalian intestinal and liver regeneration [J]. PLoS Biol, 2021, 19(2): e3001122.
[4] Morita K, He S, Nowak RP, et al. Allosteric activators of protein phosphatase 2A display broad antitumor activity mediated by dephosphorylation of MYBL2 [J]. Cell, 2020, 181(3): 702-715.
[5] Carnero A. Spinophilin: a new tumor suppressor at 17q21 [J]. Curr Mol Med, 2012, 12(5): 528-535.
[6] Wang JL, Wang Y, Sun W, et al. Spinophilin modulates pain through suppressing dendritic spine morphogenesis via negative control of Rac1-ERK signaling in rat spinal dorsal horn [J]. Neurobiol Dis, 2021, 152: 105302.
[7] Matsuura K, Kobayashi S, Konno K, et al. SIPA1L1/SPAR1 interacts with the neurabin family of proteins and is involved in GPCR signaling [J]. J Neurosci, 2022, 4(1): 112-127.
[8] 邢靖松，梁　东，克甜甜，等. 人脑胶质瘤组织中Spino- philin的表达及临床意义[J]. 临床与实验病理学杂志， 2021，37（9）：1044-1048.
[9] Verdugo-Sivianes EM, Rojas AM, Mu?oz-Galván S, et al. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells [J]. Theranostics, 2021, 11(7): 3452-3471.
[10] 祝启海，夏国庆，宋　伟. 垂体腺瘤组织DCX表达水平与 肿瘤侵袭性的关系[J]. 中国临床神经外科杂志，2021，26 （8）：597-599.
[11] 刁　艺，董　楠，杨　阳，等. GATA-6和Dickkopf-1在垂 体瘤中的表达及临床意义[J]. 河北医学，2019，25（3）： 537-542.
[12] 王　冉，周　琦，杨　坤. 垂体腺瘤侵袭性相关指标的研 究进展[J]. 临床神经外科杂志，2021，18：226-228，232.
[13] Brocos-Mosquera I, Nu?ez Del Moral A, Morentin B, et al. Characterisation of spinophilin immunoreactivity in post- mortem human brain homogenates [J]. Prog Neuropsycho- pharmacol Biol Psychiatry, 2018, 81: 236-242.
[14] Verdugo-Sivianes EM, Carnero A. Role of the holoenzyme PP1-SPN in the dephosphorylation of the RB family of tumor suppressors during cell cycle [J]. Cancers (Basel), 2021, 13(9): 2226.
[15] Hwang S, Lee PC, Shin DM, et al. Modulated start-up mode of cancer cell migration through spinophilin-tubular net- works [J]. Front Cell Dev Biol, 2021, 9: 652791.
[16] Cheerathodi M, Avci NG, Guerrero PA, et al. The cytoskele- tal adapter protein spinophilin regulates invadopodia dyna- mics and tumor cell invasion in glioblastoma [J]. Mol Cancer Res, 2016, 14(12): 1277-1287.

相似文献/References:

[1]余龙洋　李亚楠　周　宇　戴冬伟　曹依群　岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析 （附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[2]王国良　高　寒　张小鹏　公方和　李天栋.89例垂体腺瘤的手术治疗体会[J].中国临床神经外科杂志,2016,(07):435.[doi:10.13798/j.issn.1009-153X.2016.07.016]
[3]王亚平　贾晓雄　王　珺　王林林　谭溢涛　马德得　夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
　WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(05):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[4]张海红　马　磊　张　威　郭　康　衡立君　贾　栋.垂体腺瘤MRI特征与视觉功能损害的关系分析[J].中国临床神经外科杂志,2016,(01):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
　ZHANG Hai-hong,MA Lei,ZHANG Wei,et al.Analysis of MRI characteristics and visual function in patient with pituitary adenomas[J].,2016,(05):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
[5]王先祥　张义泉　李庆新　王　斌　 肖　瑾　张　科.经单鼻孔蝶窦入路神经内镜下切除垂体腺瘤[J].中国临床神经外科杂志,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
　WANG Xian-xiang,ZHANG Yi-quan,LI Qing-xin,et al.Endoscopic endonasal transsphenoidal surgery for pituitary adenomas[J].,2015,(05):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
[6]马　涛　徐　韬.经蝶入路内镜手术与显微手术治疗垂体腺瘤疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):748.[doi:10.13798/j.issn.1009-153X.2015.12.015]
[7]雷　霆.注重基础训练和知识更新，不断提高垂体腺瘤诊疗水平[J].中国临床神经外科杂志,2015,(10):577.[doi:10.13798/j.issn.1009-153X.2015.10.001]
[8]闫　进　李　松　杨　辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
　YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(05):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[9]夏为民　邵耐远　唐　科.神经内镜辅助经鼻蝶入路手术治疗急性垂体腺瘤卒中[J].中国临床神经外科杂志,2015,(07):437.[doi:10.13798/j.issn.1009-153X.2015.07.020]
[10]王齐齐　陈　俊　王焕明　胡　飞.脊索瘤合并垂体腺瘤1例[J].中国临床神经外科杂志,2015,(07):448.[doi:10.13798/j.issn.1009-153X.2015.07.025]

更新日期/Last Update: 2022-06-30